Page 31 - 林口醫研部3月電子報
P. 31
•Figure 2. Cumulative incidence in heart failure hospitalization (A), acute coronary
syndrome (B), ischemic stroke (C), and one sinus survival in all-cause mortality (D)
in T2DM patients prescribed with either SGLT2i or metformin as first-line
treatment.
Table. Study design and screening criteria flow chart for the inclusion of
T2DM patients with SGLT2i as first-line treatment and metformin as first-line
treatment.
Department of Medical Research & Development , Linkou Newsletter 31
